We have tracked every investment across both public and private psychedelics companies for the past ten years. Each year, we provide a review of the previous year’s psychedelics fundraising activity, public markets, and M&A. Here’s how Q4 and full year 2025 looked… *** raised by psychedelics companies in 2025 *** Psychedelic financing activity increased substantially in…

Source

Previous articleOp-Ed: Beyond Clinical Trials: Psychedelic-Assisted Therapy in Europe’s Real World